A RANDOMIZED OPEN-LABEL ACTIVE CONTROLLED SAFETY AND EXTRAPOLATED EFFICACY STUDY IN PEDIATRIC SUBJECTS REQUIRING ANTICOAGULATION FOR THE TREATMENT OF A VENOUS THROMBOEMBOLIC EVENT

Study Overview

The purpose of this research study is to assess the safety and efficacy of apixaban (which is a new anti-clotting drug) in the treatment of these blood clots in children.

Study Description

The purpose of this study is to assess the safety and efficacy of apixaban in the treatment of these blood clots in children.

Additional Information

Participants will be compensated for their participation.


  • IRB Number: 1606262112
  • Research Study Identifier: TX6717
  • Principal Investigator: Kerry Hege, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176